1-20 of 343 results for subject:"Medical equipment"
Librarians' tools
- Search time
- 0.249 seconds
- Solr query time
- 0.008 seconds
- Search query
- subject:"Medical equipment"
- We searched for
- subject_t:"Medical equipment" OR subject_t:"Medical devices" OR subject_ses:91970
Type
House
Session
Year
Department
More
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, whether the allocation of the £70 million for radiotherapy machines took account of existing regional variation in radiotherapy access.
To ask the Secretary of State for Health and Social Care, whether the allocation of the £70 million for radiotherapy machines took account of existing regional variation in radiotherapy access.
In December 2024, NHS England wrote to all radiotherapy treatment providers inviting them to apply for funding to replace ageing radiotherapy machines. Funding was then allocated to trusts using criteria that NHS England developed. These criteria focused on the age of the machine being replaced, the proportion of older machines in use within the trust, and the trust’s performance on radiotherapy.
The Government announced the allocation of new radiotherapy linear accelerator, or LINAC, machines on 26 May 2025, and within this, a breakdown of trust allocation was given and can be found at the following link:
https://www.gov.uk/government/news/faster-cancer-treatment-thanks-to-new-radiotherapy-machines
The following table shows allocations by National Health Service region:
Region | Total value |
East of England | £7,507,000 |
North East and Yorkshire | £7,586,000 |
Midlands | £12,406,000 |
London | £14,993,000 |
S West | £10,502,000 |
S East | £10,015,000 |
N West | £6,595,000 |
The Department knows that there is a long way to go to improve waiting times for radiotherapy treatment, and that there is significant regional variation in performance. The National Cancer Plan has set out how we intend to tackle these issues, reduce backlogs and provide an NHS that there is when people need it.
To ask the Secretary of State for Health and Social Care, what proportion of the £70 million radiotherapy machine funding announced in the Autumn Budget 2024 has been allocated to each NHS region.
To ask the Secretary of State for Health and Social Care, what proportion of the £70 million radiotherapy machine funding announced in the Autumn Budget 2024 has been allocated to each NHS region.
In December 2024, NHS England wrote to all radiotherapy treatment providers inviting them to apply for funding to replace ageing radiotherapy machines. Funding was then allocated to trusts using criteria that NHS England developed. These criteria focused on the age of the machine being replaced, the proportion of older machines in use within the trust, and the trust’s performance on radiotherapy.
The Government announced the allocation of new radiotherapy linear accelerator, or LINAC, machines on 26 May 2025, and within this, a breakdown of trust allocation was given and can be found at the following link:
https://www.gov.uk/government/news/faster-cancer-treatment-thanks-to-new-radiotherapy-machines
The following table shows allocations by National Health Service region:
Region | Total value |
East of England | £7,507,000 |
North East and Yorkshire | £7,586,000 |
Midlands | £12,406,000 |
London | £14,993,000 |
S West | £10,502,000 |
S East | £10,015,000 |
N West | £6,595,000 |
The Department knows that there is a long way to go to improve waiting times for radiotherapy treatment, and that there is significant regional variation in performance. The National Cancer Plan has set out how we intend to tackle these issues, reduce backlogs and provide an NHS that there is when people need it.
To ask the Secretary of State for Health and Social Care, if he will publish a breakdown by NHS region of where the radiotherapy machines (LINACS) funded by the £70 million announced in the Autumn Budget 2024.
To ask the Secretary of State for Health and Social Care, if he will publish a breakdown by NHS region of where the radiotherapy machines (LINACS) funded by the £70 million announced in the Autumn Budget 2024.
In December 2024, NHS England wrote to all radiotherapy treatment providers inviting them to apply for funding to replace ageing radiotherapy machines. Funding was then allocated to trusts using criteria that NHS England developed. These criteria focused on the age of the machine being replaced, the proportion of older machines in use within the trust, and the trust’s performance on radiotherapy.
The Government announced the allocation of new radiotherapy linear accelerator, or LINAC, machines on 26 May 2025, and within this, a breakdown of trust allocation was given and can be found at the following link:
https://www.gov.uk/government/news/faster-cancer-treatment-thanks-to-new-radiotherapy-machines
The following table shows allocations by National Health Service region:
Region | Total value |
East of England | £7,507,000 |
North East and Yorkshire | £7,586,000 |
Midlands | £12,406,000 |
London | £14,993,000 |
S West | £10,502,000 |
S East | £10,015,000 |
N West | £6,595,000 |
The Department knows that there is a long way to go to improve waiting times for radiotherapy treatment, and that there is significant regional variation in performance. The National Cancer Plan has set out how we intend to tackle these issues, reduce backlogs and provide an NHS that there is when people need it.
To ask the Secretary of State for Health and Social Care, what funding he is providing to support a) workplace expansion, b) equipment replacement and c) cancer pathway redesign to achieve the objectives of the National Cancer Plan.
To ask the Secretary of State for Health and Social Care, what funding he is providing to support a) workplace expansion, b) equipment replacement and c) cancer pathway redesign to achieve the objectives of the National Cancer Plan.
The National Cancer Plan, published in February 2026, aims to achieve its objectives by getting more from the resources already in the system, improving productivity, and modernising services to deliver better outcomes for patients.
The Plan is backed by significant funding committed by the Government at the Spending Review, including but not limited to a £2.3 billion investment in diagnostics to deliver an additional 9.5 million tests by 2029, over £650 million to complete the roll out of lung cancer screening by 2030, £70 million for new radiotherapy machines, and £200 million of ring-fenced funding for cancer alliances in 2026/27, to improve performance and early diagnosis. The plan also includes a £10 million fund to support children and young people with cancer and their families with travel costs.
Further decisions about the funding and provision of health services are the responsibility of integrated care boards (ICBs) who are funded by NHS England. ICBs are responsible for commissioning healthcare which best meets the needs of their local populations, including workforce expansion, equipment replacement, and pathway redesign.
Motion that this House has considered the impact of NHS workforce levels on cancer patients. Agreed to on question.
Motion that this House has considered the impact of NHS workforce levels on cancer patients. Agreed to on question.
I beg to move,
That this House has considered the impact of NHS workforce levels on cancer patients.
It is a pleasure to serve under your chairship, Ms Hobhouse. I declare an interest as a governor of the Royal Berkshire hospital. Also, a family member has shares in a medical company.
Being a...
I beg to move,
That this House has considered the impact of NHS workforce levels on cancer patients.
It is a pleasure to serve under your chairship, Ms Hobhouse. I declare an interest as a governor of the Royal Berkshire hospital. Also, a family member has shares in a medical company.
Being a...
You will not be surprised to hear, Mrs Hobhouse, that it is a pleasure to serve under you. I thank the hon. Member for Wokingham (Clive Jones) for securing this important debate. I declare an interest: my lovely wife has worked as part of the NHS workforce in Scotland for...
You will not be surprised to hear, Mrs Hobhouse, that it is a pleasure to serve under you. I thank the hon. Member for Wokingham (Clive Jones) for securing this important debate. I declare an interest: my lovely wife has worked as part of the NHS workforce in Scotland for...
It is a pleasure to serve under your chairmanship, Mrs Hobhouse. I congratulate my hon. Friend the Member for Wokingham (Clive Jones) on securing this important debate. It is unusual to be called so quickly; we are often oversubscribed, so it is a pleasure to be able to say something...
It is a pleasure to serve under your chairmanship, Mrs Hobhouse. I congratulate my hon. Friend the Member for Wokingham (Clive Jones) on securing this important debate. It is unusual to be called so quickly; we are often oversubscribed, so it is a pleasure to be able to say something...
It is a real pleasure, as always, to serve under your chairship, Mrs Hobhouse. I thank the hon. Member for Wokingham (Clive Jones) for raising this matter, which affects constituents in every part of this United Kingdom of Great Britain and Northern Ireland. I always admire the hon. Gentleman because...
It is a real pleasure, as always, to serve under your chairship, Mrs Hobhouse. I thank the hon. Member for Wokingham (Clive Jones) for raising this matter, which affects constituents in every part of this United Kingdom of Great Britain and Northern Ireland. I always admire the hon. Gentleman because...
I know that this subject is important to the hon. Gentleman. Pancreatic Cancer UK is a fantastic charity. Unfortunately, he could not make this year’s Labour party conference in Liverpool, although he is always welcome to attend—Labour MPs go free, so he is welcome to join up. However, Pancreatic Cancer...
I know that this subject is important to the hon. Gentleman. Pancreatic Cancer UK is a fantastic charity. Unfortunately, he could not make this year’s Labour party conference in Liverpool, although he is always welcome to attend—Labour MPs go free, so he is welcome to join up. However, Pancreatic Cancer...
I welcome the hon. Gentleman’s encouraging intervention. That is what it is all about. Of course, I attend my own party’s conference—I am not sure I would attend anyone else’s. Party conferences are a great opportunity to meet groups that are working hard, and they come to our conference too....
I welcome the hon. Gentleman’s encouraging intervention. That is what it is all about. Of course, I attend my own party’s conference—I am not sure I would attend anyone else’s. Party conferences are a great opportunity to meet groups that are working hard, and they come to our conference too....
It is a pleasure to serve under your chairship, Mrs Hobhouse. I thank my hon. Friend the Member for Wokingham (Clive Jones) for securing this important debate highlighting the issue of staff shortages and the impact on cancer patients and the outcomes that they achieve.
Cancer should be a top priority...
It is a pleasure to serve under your chairship, Mrs Hobhouse. I thank my hon. Friend the Member for Wokingham (Clive Jones) for securing this important debate highlighting the issue of staff shortages and the impact on cancer patients and the outcomes that they achieve.
Cancer should be a top priority...
It is a pleasure to serve under your chairmanship this afternoon, Mrs Hobhouse. I congratulate the hon. Member for Wokingham (Clive Jones) on securing this debate.
Across the United Kingdom, an estimated 3.5 million people are living with cancer. We all know a friend, family member or co-worker who has battled...
It is a pleasure to serve under your chairmanship this afternoon, Mrs Hobhouse. I congratulate the hon. Member for Wokingham (Clive Jones) on securing this debate.
Across the United Kingdom, an estimated 3.5 million people are living with cancer. We all know a friend, family member or co-worker who has battled...
It is a pleasure to serve under your chairship, Mrs Hobhouse. I thank the hon. Member for Wokingham (Clive Jones) for securing the debate, and for getting through it—I hope he is well. I thank other hon. Members for their contributions. As others have noted, I am aware of the...
It is a pleasure to serve under your chairship, Mrs Hobhouse. I thank the hon. Member for Wokingham (Clive Jones) for securing the debate, and for getting through it—I hope he is well. I thank other hon. Members for their contributions. As others have noted, I am aware of the...
I thank the Minister for giving way. As ever, she is most generous with her time. She has outlined the positive steps that the Government are taking to address the workforce challenge. Could she elaborate on the points I made about the inequalities between the north and the south in...
I thank the Minister for giving way. As ever, she is most generous with her time. She has outlined the positive steps that the Government are taking to address the workforce challenge. Could she elaborate on the points I made about the inequalities between the north and the south in...
I do not have those numbers to hand but, as we outlined in the 10-year health plan, we are particularly committed to people in rural and coastal communities with regard to workforce and access to many other services. If there is anything specific the hon. Gentleman is not aware of,...
I do not have those numbers to hand but, as we outlined in the 10-year health plan, we are particularly committed to people in rural and coastal communities with regard to workforce and access to many other services. If there is anything specific the hon. Gentleman is not aware of,...
I thank you, Mrs Hobhouse, and the Minister for leaving me time to sum up the debate. I thank my hon. Friend the Member for North Shropshire (Helen Morgan) for her contribution and her kind remarks, and I thank other Members for their kind remarks as well. I thank all...
I thank you, Mrs Hobhouse, and the Minister for leaving me time to sum up the debate. I thank my hon. Friend the Member for North Shropshire (Helen Morgan) for her contribution and her kind remarks, and I thank other Members for their kind remarks as well. I thank all...
Will the hon. Gentleman give way?
Will the hon. Gentleman give way?
I will make some progress.
I must also say a big thank you to all the cancer charities and life sciences companies that have provided valuable insight into the state of the NHS workforce and its effect on cancer patients. The impact of NHS workforce levels on cancer patients is a...
I will make some progress.
I must also say a big thank you to all the cancer charities and life sciences companies that have provided valuable insight into the state of the NHS workforce and its effect on cancer patients. The impact of NHS workforce levels on cancer patients is a...